- 专利标题: THERAPEUTIC DRUG FOR LIPID-PEROXIDATION-INDUCED DISEASES AND SCREENING METHOD FOR THERAPEUTIC DRUGS FOR LIPID-PEROXIDATION-INDUCED DISEASES
-
申请号: US18300582申请日: 2023-04-14
-
公开(公告)号: US20230324359A1公开(公告)日: 2023-10-12
- 发明人: Ken-ichi YAMADA , Saki SHINTO , Tomomi IDE , Keiichi YAMAMOTO
- 申请人: Ken-ichi YAMADA , FUSO PHARMACEUTICAL INDUSTRIES, LTD.
- 申请人地址: JP Fukuoka-shi
- 专利权人: Ken-ichi YAMADA,FUSO PHARMACEUTICAL INDUSTRIES, LTD.
- 当前专利权人: Ken-ichi YAMADA,FUSO PHARMACEUTICAL INDUSTRIES, LTD.
- 当前专利权人地址: JP Fukuoka-shi
- 优先权: JP 17132772 2017.07.06
- 分案原申请号: US17979453 2022.11.02
- 主分类号: G01N33/15
- IPC分类号: G01N33/15 ; C07D413/12 ; C01G49/14 ; C07C57/00 ; C12N5/071 ; G01N33/52 ; C40B20/08
摘要:
The present invention provides: an assay method that uses a compound represented by formula (I) as a fluorescent probe molecule and that is for detecting the lipid peroxidation suppression activity of a test compound; an assay kit that uses the assay method; a screening method that uses the assay method; and a pharmaceutical composition that is for the treatment, etc. of diseases (such as age-related macular degeneration) that are induced by lipid peroxidation reactions.
信息查询